These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 21395124)

  • 21. Myeloablative chemotherapy with autologous peripheral blood stem cell transplantation in patients with poor-prognosis solid tumors - Bulgarian experience.
    Avramova B; Jordanova M; Michailov G; Konstantinov D; Christosova I; Bobev D
    J BUON; 2006; 11(4):433-8. PubMed ID: 17309174
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Germ-cell tumors of the central nervous system in childhood: retrospective study of 13 patients].
    Voirin J; Klein O; Chastagner P; Moret C; Vignaud JM; Auque J; Marchal JC
    Neurochirurgie; 2008 Apr; 54(2):55-62. PubMed ID: 18355878
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of surgery, chemotherapy and irradiation on long term outcome of intracranial malignant non-germinomatous germ cell tumors: results of the German Cooperative Trial MAKEI 89.
    Calaminus G; Bamberg M; Jürgens H; Kortmann RD; Sörensen N; Wiestler OD; Göbel U
    Klin Padiatr; 2004; 216(3):141-9. PubMed ID: 15175958
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The European experience with megadose therapy and autologous bone marrow transplantation in solid tumors with poor prognosis Ewing sarcoma, germ cell tumors and brain tumors)].
    Ladenstein R; Gadner H; Hartmann O; Pico J; Biron P; Thierry P
    Wien Med Wochenschr; 1995; 145(2-3):55-7. PubMed ID: 7762255
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Autologous tumor specific immunotherapy of refractory cancers with ex vivo-generated T cells stimulated by autologous tumor cell].
    Toh U; Yamana H; Kido K; Mine T; Fujii T; Horiuchi H; Sasatomi T; Ishibashi N; Yutani S; Fujita H; Shirouzu K
    Gan To Kagaku Ryoho; 2003 Oct; 30(11):1566-70. PubMed ID: 14619465
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Observations on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2 to patients with metastatic cancer.
    Rosenberg SA; Lotze MT; Muul LM; Leitman S; Chang AE; Ettinghausen SE; Matory YL; Skibber JM; Shiloni E; Vetto JT
    N Engl J Med; 1985 Dec; 313(23):1485-92. PubMed ID: 3903508
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modification of lymphokine-activated killer cell accumulation into tumor sites by chemotherapy, local irradiation, or splenectomy.
    Kawata A; Hosokawa M; Sawamura Y; Ito K; Une Y; Shibata T; Uchino J; Kobayashi H
    Mol Biother; 1990 Dec; 2(4):221-7. PubMed ID: 2288722
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Single and double high-dose chemotherapy with autologous stem cell transplantation in children with advanced solid tumors: first experiences].
    Kühne T; Staehelin F; Avoledo P; Tichelli A; Passweg J; Imbach P; Gratwohl A
    Schweiz Med Wochenschr; 2000 Mar; 130(12):419-25. PubMed ID: 10780056
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Treatment outcome of children and adolescents with germ cell tumor after combined therapy---a report of 44 cases].
    Sun XF; Yang QY; Zhen ZJ; Xia Y; Huang ZH; Ling JY
    Ai Zheng; 2006 Dec; 25(12):1529-32. PubMed ID: 17166380
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interleukin-2 with or without LAK cells in metastatic renal cell carcinoma: a report of a European multicentre study.
    Negrier S; Philip T; Stoter G; Fossa SD; Janssen S; Iacone A; Cleton FS; Eremin O; Israel L; Jasmin C
    Eur J Cancer Clin Oncol; 1989; 25 Suppl 3():S21-8. PubMed ID: 2697575
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Exogenous interleukin 2 recruits in vitro lymphokine-activated killer activity by in vivo activated lymphocytes.
    Lamers HJ; Gratama JW; van Putten WL; Stoter G; Bolhuis RL
    Cancer Res; 1991 May; 51(9):2324-8. PubMed ID: 2015597
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The clinical study of local treatment of ocular malignant tumors with IL-2 LAK cells].
    Yang L; Zhang J; Liang G
    Zhonghua Yan Ke Za Zhi; 1995 May; 31(3):215-7. PubMed ID: 7555407
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intensive chemotherapy with autologous peripheral blood stem cell transplantation during a 10-year period in 64 patients with germ cell tumor.
    Müller AM; Ihorst G; Waller CF; Dölken G; Finke J; Engelhardt M
    Biol Blood Marrow Transplant; 2006 Mar; 12(3):355-65. PubMed ID: 16503505
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enhancement of antitumor response to sarcoma 45 in rats by combination of whole-body hyperthermia and interleukin-2.
    Potapnev MP; Istomin YP; Ismail-zade RS; Zhavrid EA
    Eksp Onkol; 2004 Mar; 26(1):67-70. PubMed ID: 15112583
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stress induced changes in lymphocyte subpopulations and associated cytokines during whole body hyperthermia of 41.8-42.2 degrees C.
    Ahlers O; Hildebrandt B; Dieing A; Deja M; Böhnke T; Wust P; Riess H; Gerlach H; Kerner T
    Eur J Appl Physiol; 2005 Oct; 95(4):298-306. PubMed ID: 16096838
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Significance of blood purification in cancer therapy].
    Toge T
    Nihon Rinsho; 1992 Jan; 50 Suppl():357-63. PubMed ID: 1533693
    [No Abstract]   [Full Text] [Related]  

  • 37. [Hyperthermic immuno-cellular therapy-basic and clinical study].
    Takeda T; Fukunaga K; Miyazawa K; Takahashi T; Takeda H; Takeda Y; Tanigawa K; Morisaki T; Yamamoto I; Hasegawa T
    Gan To Kagaku Ryoho; 2008 Nov; 35(12):2244-6. PubMed ID: 19106584
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Hyperthermia in oncology--a need for centers with competence and standards].
    Issels R; Hiddemann W
    Dtsch Med Wochenschr; 2003 Sep; 128(39):1997. PubMed ID: 14508693
    [No Abstract]   [Full Text] [Related]  

  • 39. The Role of Hyperthermia in the Multidisciplinary Treatment of Malignant Tumors.
    Cheng Y; Weng S; Yu L; Zhu N; Yang M; Yuan Y
    Integr Cancer Ther; 2019; 18():1534735419876345. PubMed ID: 31522574
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Posttransplant adoptive immunotherapy with interleukin-2 in children suffering from neuroectodermal tumors with poor prognosis.
    Kałwak K; Ussowicz M; Gorczyńska E; Toporski J; Turkiewicz D; Bogusławska-Jaworska J; Chybicka A
    Transplant Proc; 2002 Mar; 34(2):665-7. PubMed ID: 12009658
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.